Science
Mechanism of Action
This synthetic biomimetic peptide precisely mimics a specific ligand-binding sequence of the EDA1 protein, directly interacting with the Ectodysplasin A receptor (EDAR). EDAR activation is fundamental for embryonic skin development. Upon topical application, Oligopeptide-71 initiates the WNT signaling pathway through NF-kB activation, leading to its reported benefits for skin health and regeneration.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
As with many peptides, Oligopeptide-71 is prone to degradation through processes such as sulfur-containing amino acid oxidation and oligomerization. Optimal stability requires storage sealed away from light at 2-8°C, with -15 to -20°C recommended for extended preservation. Precise pH control during formulation is critical for maintaining its integrity.
Safety
Safety Profile
Manufacturers state Oligopeptide-71 is free of heavy metals and elicits no skin or eye irritation. It is important to note that concerns regarding the scientific basis of clinical studies and unknown long-term risks have been raised for sh-oligopeptide-1, a distinct oligopeptide, and do not directly apply to Oligopeptide-71.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Given the established mechanistic insights into its role in skin development and regeneration, but the current absence of specific, peer-reviewed clinical data for Oligopeptide-71 itself, more research is needed to quantify its precise efficacy in cosmetic applications.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources